Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Melzer

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Journal of Neurology|February 18, 2016
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyNico Melzer, Tobias Ruck, Peter Fuhr, et al.
Stem Cell Research|August 2, 2025
Reprogramming Patient-Derived urine cells into iPSCs for Anti-GAD65 autoimmune encephalitis researchHaribaskar Ramachandran, Saskia Räuber, Jochen Dobner, et al.
Acta Neuropathologica|June 13, 2022
Complement activation contributes to GAD antibody-associated encephalitisOmar Chuquisana, Christine Strippel, Anna M Tröscher, et al.
Oxford Medical Case Reports|July 7, 2017
Treating refractory post-herpetic anti-<i>N</i>-methyl-d-aspartate receptor encephalitis with rituximabChristine Strippel, Constanze Mönig, Kristin S Golombeck, et al.
Journal of Neuroimmunology|June 30, 2018
Immune cell profiling in the cerebrospinal fluid of patients with primary angiitis of the central nervous system reflects the heterogeneity of the diseaseDaniel Strunk, Andreas Schulte-Mecklenbeck, Kristin S Golombeck, et al.
Epilepsy & Behavior : E&B|December 18, 2019
Low CSF CD4/CD8+ T-cell proportions are associated with blood-CSF barrier dysfunction in limbic encephalitisNiels Hansen, Kerstin Schwing, Demet Önder, et al.
Brain Pathology (Zurich, Switzerland)|January 4, 2023
The neurovasculature as a target in temporal lobe epilepsyYvonne Reiss, Sebastian Bauer, Bastian David, et al.
Multiple Sclerosis and Related Disorders|March 8, 2026
Altered network recruitment in multiple sclerosis patients during resting stateAnnika Lüttjohann, Saskia Räuber, Melanie Korsen, et al.
Epilepsia|February 11, 2025
A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathiesElisa Buhleier, Susanne Schubert-Bast, Susanne Knake, et al.
Annals of Clinical and Translational Neurology|November 5, 2019
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosisChristian W Keller, Tobias Ruck, Donal McHugh, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Neurology|February 18, 2016
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological SocietyNico Melzer, Tobias Ruck, Peter Fuhr, et al.
Stem Cell Research|August 2, 2025
Reprogramming Patient-Derived urine cells into iPSCs for Anti-GAD65 autoimmune encephalitis researchHaribaskar Ramachandran, Saskia Räuber, Jochen Dobner, et al.
Acta Neuropathologica|June 13, 2022
Complement activation contributes to GAD antibody-associated encephalitisOmar Chuquisana, Christine Strippel, Anna M Tröscher, et al.
Oxford Medical Case Reports|July 7, 2017
Treating refractory post-herpetic anti-<i>N</i>-methyl-d-aspartate receptor encephalitis with rituximabChristine Strippel, Constanze Mönig, Kristin S Golombeck, et al.
Journal of Neuroimmunology|June 30, 2018
Immune cell profiling in the cerebrospinal fluid of patients with primary angiitis of the central nervous system reflects the heterogeneity of the diseaseDaniel Strunk, Andreas Schulte-Mecklenbeck, Kristin S Golombeck, et al.
Epilepsy & Behavior : E&B|December 18, 2019
Low CSF CD4/CD8+ T-cell proportions are associated with blood-CSF barrier dysfunction in limbic encephalitisNiels Hansen, Kerstin Schwing, Demet Önder, et al.
Brain Pathology (Zurich, Switzerland)|January 4, 2023
The neurovasculature as a target in temporal lobe epilepsyYvonne Reiss, Sebastian Bauer, Bastian David, et al.
Multiple Sclerosis and Related Disorders|March 8, 2026
Altered network recruitment in multiple sclerosis patients during resting stateAnnika Lüttjohann, Saskia Räuber, Melanie Korsen, et al.
Epilepsia|February 11, 2025
A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathiesElisa Buhleier, Susanne Schubert-Bast, Susanne Knake, et al.
Annals of Clinical and Translational Neurology|November 5, 2019
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosisChristian W Keller, Tobias Ruck, Donal McHugh, et al.
Pageof 15